HLA B*Allele and HIV Disease Progression in Ugandans
Author Information
Author(s): Serwanga Jennifer, Shafer Leigh Anne, Pimego Edward, Auma Betty, Watera Christine, Rowland Samantha, Yirrell David, Pala Pietro, Grosskurth Heiner, Whitworth Jimmy, Gotch Frances, Kaleebu Pontiano
Primary Institution: MRC/UVRI Uganda Research Unit on AIDS
Hypothesis
Does the presence of specific HLA B alleles correlate with slower HIV-1 disease progression in antiretroviral therapy-naïve individuals?
Conclusion
The study found that slow HIV disease progression is associated with the presence of protective HLA B alleles and better virological control.
Supporting Evidence
- Slow progressors had a higher frequency of protective HLA B alleles compared to rapid progressors.
- Virological control was significantly better in slow progressors than in rapid progressors.
- Multiclade Gag T-cell recognition was more common in slow progressors.
Takeaway
Some people with HIV can stay healthy for a long time without medicine, and this study found that certain genes help them do that.
Methodology
Multilevel regression modeling was used to classify HIV-infected individuals based on CD4 T cell slopes, and ELISpot assays quantified HIV-specific T-cell responses.
Potential Biases
Potential biases may arise from the retrospective nature of CD4 count data and participant selection.
Limitations
The study's sample size was limited, which may affect the reliability of the findings.
Participant Demographics
The cohort consisted of 110 HIV-infected individuals, predominantly female, with a median age of 37 years.
Statistical Information
P-Value
p=0.004
Confidence Interval
95% CI −28 to −14
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website